miR-155 has also been seen to promote inflammatory activation of macrophages by repressing B-cell leukemia/lymphoma (BCL) 6, a negative regulator of NF-κB signaling, thus promoting atherosclerosis [126]. Here, NFKB1 is linked to atherosclerosis.